OHAir MySpace Hydroxyl Unit Covid-19

OHAir® MySpace Hydroxyl Purification Unit

OHAir® Hydroxyl technology has been tested by the Chinese National Institute for Viral Disease Control and Prevention. The test proved a 99.99% destruction of the COVID-19 virus in less than one hour.

The OHAir® MySpace Hydroxyl Unit is available for purchase outright for $1200.00 each, 6 or more for $1100.00 each, 9 or more for $990 each or rental for $450.00 per monthly basis (equal to $15 per day). Prices inc. GST, Postage and Handling. Available in Orange & Surrounding Areas Only.

$1200 (single unit)

McArdles Cleaning & Restoration Services

OHAir® MySpace Hydroxyl Unit Purchase

Billing Adress

$450.00 ($15.00) Per Day at Monthly Rental.

McArdles Cleaning & Restoration Services

OHAir® MySpace Hydroxyl Unit Rental

Billing Address

    $1100 for 6+Units / $990 for 9+ Units

    For more than one unit, enquire now:

    Harnessing the Power of the Sun

    To date, current technologies utilised to clean indoor air have their limitations. OHAir® products are unique, due to the high level of effectiveness and safety they provide to you and your family.

    • Destroys 99.9% In Air and On Surfaces
    • Odours/VOC’s
    • Influenza
    • Mould
    • E.Coli
    • Staphylococcus
    • Viruses & Baterias
    • Other Chemical
    Hydroxyl Treatment Machines

    The OHAir® unit contains a uniquely designed HGU (Hydroxyl Generation Unit) that operates at specific wavelengths to reproduce the effect of the sun’s ultra-violet light but inside your house.

    This is a bit technical, but this how OHAir® technology works:

    1. A pulse of low-wavelength light from the HGU (Hydroxyl Generation Unit) interacts with a water molecule in the air (H2O) removing a hydrogen atom resulting in the creation of a hydroxyl molecule consisting of an oxygen and hydrogen atom (OH).
    2. The newly generated hydroxyl is in a dynamic state as it seeks to recover the hydrogen atom from any molecule it interacts with to convert back to a water molecule.
    3. The Constant Stream effect of the OHAir® unit continues the ongoing generation of hydroxyls, spreading them within the air and onto surfaces in the room.
    4. The dynamic nature of the hydroxyl molecule results in the destruction of any bacteria and virus it contacts by penetrating their cell walls and removes any volatile organic chemicals such as chlorine and ammonia by changing their chemical composition.

    The OHAir® technology – MySpace and MDU5 has also been operationally tested in several hospitals in Wuhan and orders confirmed as a result. OHAir® Hydroxyl technology is the only technology available that can actively reduce the viral contamination in occupied spaces, reducing the risk of cross-contamination.

    The OHAir® difference is that the air does not need to go through the unit as it emits a safe treatment for the entire room. The OHAir® technology has also been through FDAs rigorous safety and efficacy testing where it demonstrated up to a 99.99999% reduction in Virus, bacteria and mould within 2-3 hours.

    • FDA Approved for Medical Facilities

    • Laboratory Tested & Passed
    • Works safely in occupied spaces
    • Great for all types of odours
    • Destroys 99.9% of influenza, E.Coli and mould, in-air and on-surface

    Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1

    A novel human coronavirus that is now named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (formerly called HCoV-19) emerged in Wuhan, China, in late 2019 and is now causing a pandemic. We analyzed the aerosol and surface stability of SARS-CoV-2 and compared it with SARS-CoV-1, the most closely related human coronavirus.

    We evaluated the stability of SARS-CoV-2 and SARS-CoV-1 in aerosols and on various surfaces and estimated their decay rates using a Bayesian regression model (see the Methods section in the Supplementary Appendix, available with the full text of this letter at NEJM.org). SARS-CoV-2 nCoV-WA1-2020 (MN985325.1) and SARS-CoV-1 Tor2 (AY274119.3) were the strains used. Aerosols (<5 μm) containing SARS-CoV-2 (105.25 50% tissue-culture infectious dose [TCID50] per milliliter) or SARS-CoV-1 (106.75-7.00 TCID50 per milliliter) were generated with the use of a three-jet Collison nebulizer and fed into a Goldberg drum to create an aerosolized environment. The inoculum resulted in cycle-threshold values between 20 and 22, similar to those observed in samples obtained from the upper and lower respiratory tract in humans.

    Our data consisted of 10 experimental conditions involving two viruses (SARS-CoV-2 and SARS-CoV-1) in five environmental conditions (aerosols, plastic, stainless steel, copper, and cardboard). All experimental measurements are reported as means across three replicates.

    SARS-CoV-2 remained viable in aerosols throughout the duration of our experiment (3 hours), with a reduction in infectious titer from 103.5 to 102.7 TCID50 per liter of air. This reduction was similar to that observed with SARS-CoV-1, from 104.3 to 103.5 TCID50 per milliliter.

    SARS-CoV-2 was more stable on plastic and stainless steel than on copper and cardboard, and viable virus was detected up to 72 hours after application to these surfaces (Figure 1A), although the virus titer was greatly reduced (from 103.7 to 100.6 TCID50 per milliliter of medium after 72 hours on plastic and from 103.7 to 100.6 TCID50 per milliliter after 48 hours on stainless steel). The stability kinetics of SARS-CoV-1 were similar (from 103.4 to 100.7 TCID50 per milliliter after 72 hours on plastic and from 103.6 to 100.6 TCID50 per milliliter after 48 hours on stainless steel). On copper, no viable SARS-CoV-2 was measured after 4 hours and no viable SARS-CoV-1 was measured after 8 hours. On cardboard, no viable SARS-CoV-2 was measured after 24 hours and no viable SARS-CoV-1 was measured after 8 hours.

    Both viruses had an exponential decay in virus titer across all experimental conditions, as indicated by a linear decrease in the log10TCID50 per liter of air or milliliter of medium over time (Figure 1B). The half-lives of SARS-CoV-2 and SARS-CoV-1 were similar in aerosols, with median estimates of approximately 1.1 to 1.2 hours and 95% credible intervals of 0.64 to 2.64 for SARS-CoV-2 and 0.78 to 2.43 for SARS-CoV-1 (Figure 1C, and Table S1 in the Supplementary Appendix). The half-lives of the two viruses were also similar on copper. On cardboard, the half-life of SARS-CoV-2 was longer than that of SARS-CoV-1. The longest viability of both viruses was on stainless steel and plastic; the estimated median half-life of SARS-CoV-2 was approximately 5.6 hours on stainless steel and 6.8 hours on plastic (Figure 1C). Estimated differences in the half-lives of the two viruses were small except for those on cardboard (Figure 1C). Individual replicate data were noticeably “noisier” (i.e., there was more variation in the experiment, resulting in a larger standard error) for cardboard than for other surfaces (Fig. S1 through S5), so we advise caution in interpreting this result.

    We found that the stability of SARS-CoV-2 was similar to that of SARS-CoV-1 under the experimental circumstances tested. This indicates that differences in the epidemiologic characteristics of these viruses probably arise from other factors, including high viral loads in the upper respiratory tract and the potential for persons infected with SARS-CoV-2 to shed and transmit the virus while asymptomatic.3,4 Our results indicate that aerosol and fomite transmission of SARS-CoV-2 is plausible, since the virus can remain viable and infectious in aerosols for hours and on surfaces up to days (depending on the inoculum shed). These findings echo those with SARS-CoV-1, in which these forms of transmission were associated with nosocomial spread and super-spreading events,5 and they provide information for pandemic mitigation efforts.

    Neeltje van Doremalen, Ph.D.
    Trenton Bushmaker, B.Sc.
    National Institute of Allergy and Infectious Diseases, Hamilton, MT

    Dylan H. Morris, M.Phil.
    Princeton University, Princeton, NJ

    Myndi G. Holbrook, B.Sc.
    National Institute of Allergy and Infectious Diseases, Hamilton, MT

    Amandine Gamble, Ph.D.
    University of California, Los Angeles, Los Angeles, CA

    Brandi N. Williamson, M.P.H.
    National Institute of Allergy and Infectious Diseases, Hamilton, MT

    Azaibi Tamin, Ph.D.
    Jennifer L. Harcourt, Ph.D.
    Natalie J. Thornburg, Ph.D.
    Susan I. Gerber, M.D.
    Centers for Disease Control and Prevention, Atlanta, GA

    James O. Lloyd-Smith, Ph.D.
    University of California, Los Angeles, Los Angeles, CA, Bethesda, MD

    Emmie de Wit, Ph.D.
    Vincent J. Munster, Ph.D.
    National Institute of Allergy and Infectious Diseases, Hamilton, MT

    Odorox® Eliminated >99.99% of Two Viruses Selected for Testing by the FDA

    Odorox® Hydroxyl Group is a leading supplier of Odorox® – the only patented and scientifically proven hydroxyl technology in the marketplace today. The airborne hydroxyl radicals created by Odorox® work by treating pathogens in both the air and on surfaces. These radicals are scientifically known to react one million times faster than ozone, bleach, or other cleaning agents.

    What does that mean for the Coronavirus?

    Aerosol Research & Engineering Laboratories (ARE) tested the Odorox® MDU/Rx following FDA guidelines. All five tests on FDA-selected viruses, bacteria, and mold had kill rates of between 4 and 5 log reductions (99.99% – 99.999%) within two hours – an exceptionally high and fast kill rate. FDA then approved the Odorox® MDU/Rx as a Class II Medical Device for use in occupied areas.

    To be clear, testing a new virulent virus like the Coronavirus is not possible for several reasons. First, only major national labs like the CDC and NIH get samples so soon after the emergence of the virus. Second, commercial labs are not equipped to test them as it would require biosafety containment facilities and protocols beyond their capability.

    However, one of the viruses chosen by the FDA when testing Odorox® was the MS2 virus. Based on what is known about the new Coronavirus, it is believed that the MS2 virus is an excellent surrogate as it too is a positive-sense, single-stranded, RNA virus. The FDA considered it a routine simulant for pathogenic RNA viruses and said the test results were “exceptional”.

    Odorox® machines are used in spaces from small bedrooms to large scale areas such as offices, commercial buildings, healthcare facilities, schools and universities, etc. They require no work on your end – just plug them in and turn them on.

    Odorox® machines operate around the clock – 24 hours a day. They are an extremely effective tool for killing airborne microorganisms and treating hard to reach areas. This is particularly important when treating viral diseases, like Coronavirus, as the main vector for transmission is inhalation of the aerosolized virus.

    Only needing to plug in Odorox® makes the treatment process less time consuming and reduces the stress that comes with continually having to respray and repeatedly wipe all surfaces as new pathogens enter the area. It is recommended to incorporate Odorox® in conjunction with other surface cleaning protocols to create the safest and cleanest environments.

    The Coronavirus, or COVID-19 is a contagious viral infection that has many people worried. This world-wide virus has the potential to have a huge impact on almost any industry in our current global economy. Here at OdoroxⓇ, we have been flooded with questions and requests for information on what our technology might do to help contain this and other microbiological elements. We put together the following FAQ to help.

    Has your product been tested to be effective against viruses and bacteria?
    Yes, the ability of OdoroxⓇ machines to kill viruses, bacteria, and mold was scientifically proven back in December 2014, when the OdoroxⓇ MDU/Rx machine was tested and approved by the FDA as a Class II Medical Device in occupied areas.

    What data do you have to prove this?
    Our machines were tested at the Aerosol Research and Engineering Laboratories (ARE), an independent commercial laboratory that specializes in studying aerosolized microbiological organisms. These tests were performed on viruses, bacteria, and mold chosen by the FDA as some of the toughest. These viruses and bacteria were aerosolized in the test, mimicking the way they are often transmitted through actions like people coughing. We did this to obtain FDA approval for the OdoroxⓇ MDU/Rx machine. All of the tests had kill rates of between 4 and 5 log reductions (99.99% and 99.999%) within 2 hours: an exceptionally high (and fast) kill rate. If you want more data, we have detailed information documented by the Head of our Scientific Advisory Board on the independent microbiological laboratory testing that was performed.

    Has your product been tested to be effective against the Coronavirus, or COVID-19,  specifically?
    No – this is not possible at this time. Only the top national labs like the CDC and NIH can get samples of the Coronavirus so soon after an outbreak like this. Commercial labs are not equipped with the biosafety measures and containment protocols needed to test these types of viruses. However, one of the viruses included in the ARE laboratory testing was the MS2 virus, which is an excellent surrogate for the Coronavirus as both are positive-sense single-stranded RNA, or (+)ssRNA viruses. Based on this, we believe that the OdoroxⓇ MDU/Rx machine will be effective against the Coronavirus.

    Which OdoroxⓇ machine is the best for killing viruses and bacteria?
    The OdoroxⓇ MDU/Rx machine was tested and approved by the FDA as a Class II Medical Device for use in occupied areas. We have two other OdoroxⓇ machines that are built exactly the same as that unit but they are more powerful – they are the Oasis+ and the Boss machines. Any of those OdoroxⓇ machines would be great assets to add to an infection control protocol that would also include things like spraying chemicals, wiping surfaces, and other effective disinfection methods.

    How do the Odorox machines work?
    It’s incredibly easy: You just plug it in and turn it on. Our machines replicate the natural production of hydroxyl radicals to completely eliminate biological and chemical contaminants. These hydroxyls work on both the air and on surfaces while the spaces are occupied and in use. They can run 24/7, require very little labor, and leave little room for human error.

    Where can these machines be used?
    Our OdoroxⓇ Technology is ideal for any type of commercial building that has been or could be exposed to the Coronavirus, such as: apartment buildings, condominiums, hotels, big box retailers, universities and schools, manufacturing and industrial warehouse facilities, hospitals, churches, theaters, airports, office buildings, government establishments, and many other high traffic public facilities.

    They are safe to use while the building is occupied and in use.